Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration

Xuezhao Liu,Dazhuan Eric Xin,Xiaowen Zhong,Chuntao Zhao,Zhidan Li,Liguo Zhang,Adam J. Dourson,Lindsay Lee,Shreya Mishra,Arman E. Bayat,Eva Nicholson,William L. Seibel,Bingfang Yan,Joel Mason,Bradley J. Turner,David G. Gonsalvez,William Ong,Sing Yian Chew,Balaram Ghosh,Sung Ok Yoon,Mei Xin,Zhigang He,Jason Tchieu,Michael Wegner,Klaus-Armin Nave,Robin J.M. Franklin,Ranjan Dutta,Bruce D. Trapp,Ming Hu,Matthew A. Smith,Michael P. Jankowski,Samantha K. Barton,Xuelian He,Q. Richard Lu
DOI: https://doi.org/10.1016/j.cell.2024.04.005
2024-05-05
Cell Journal
Abstract:Highlights • An epigenetic barrier impedes myelin production in multiple sclerosis lesions • Small-molecule inhibitor ESI1 promotes CNS myelin production and regeneration • ESI1 enhances (re)myelination in aged mice while reversing cognitive decline • ESI1-induced active chromatin landscape and SREBP condensation boost myelinogenesis Summary Remyelination failure in diseases like multiple sclerosis (MS) was thought to involve suppressed maturation of oligodendrocyte precursors; however, oligodendrocytes are present in MS lesions yet lack myelin production. We found that oligodendrocytes in the lesions are epigenetically silenced. Developing a transgenic reporter labeling differentiated oligodendrocytes for phenotypic screening, we identified a small-molecule epigenetic-silencing-inhibitor (ESI1) that enhances myelin production and ensheathment. ESI1 promotes remyelination in animal models of demyelination and enables de novo myelinogenesis on regenerated CNS axons. ESI1 treatment lengthened myelin sheaths in human iPSC-derived organoids and augmented (re)myelination in aged mice while reversing age-related cognitive decline. Multi-omics revealed that ESI1 induces an active chromatin landscape that activates myelinogenic pathways and reprograms metabolism. Notably, ESI1 triggered nuclear condensate formation of master lipid-metabolic regulators SREBP1/2, concentrating transcriptional co-activators to drive lipid/cholesterol biosynthesis. Our study highlights the potential of targeting epigenetic silencing to enable CNS myelin regeneration in demyelinating diseases and aging. Graphical abstract Download : Download high-res image (271KB) Download : Download full-size image
cell biology
What problem does this paper attempt to address?